Development and validation of a patient-report measure of fatigue associated with depression

Journal of Affective Disorders

Volumn 134, Issue 1-3, 2011, Pages 294-303

  Matza, Louis S ^a   Phillips, Glenn A ^b   Revicki, Dennis A ^a   Murray, Lindsey ^a   Malley, Karen G ^c  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c Malley Research Programming Inc   (United States)

Author keywords

Depression; Fatigue; Instrument development; Patient reported outcomes; Psychometric validation; Residual symptoms

Indexed keywords

SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BRIEF FATIGUE INVENTORY; CLINICAL GLOBAL IMPRESSION SCALE; CONSTRUCT VALIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; EPWORTH SLEEPINESS SCALE; FATIGUE; FATIGUE ASSOCIATED WITH DEPRESSION QUESTIONNAIRE; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERVIEW; INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY SELF REPORT; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; SHORT FORM 36; TEST RETEST RELIABILITY;

ADULT; DEPRESSION; DEPRESSIVE DISORDER; FACTOR ANALYSIS, STATISTICAL; FATIGUE; FEMALE; FOCUS GROUPS; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RESEARCH REPORT; WEIGHTS AND MEASURES;

EID: 80052507427     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.06.028     Document Type: Article

References (54)

1. L.M. Arnold Understanding fatigue in major depressive disorder and other medical disorders Psychosomatics 49 2008 185 190 (Pubitemid 351668718)
2. M. Barkham, A. Rees, W.B. Stiles, D.A. Shapiro, G.E. Hardy, and S. Reynolds Dose-effect relations in time-limited psychotherapy for depression J. Consult. Clin. Psychol. 64 1996 927 935 (Pubitemid 26349571)
3. D. Cella Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Scales 1997 Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University Center on Outcomes
4. T. Chalder, G. Berelowitz, T. Pawlikowska, L. Watts, S. Wessely, D. Wright, and E.P. Wallace Development of a fatigue scale J. Psychosom. Res. 37 1993 147 153 (Pubitemid 23128452)
5. K. Demyttenaere, J. De Fruyt, and S.M. Stahl The many faces of fatigue in major depressive disorder Int. J. Neuropsychopharmacol. 8 2005 93 105 (Pubitemid 40388818)
6. M. Fava Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment J. Clin. Psychiatry 64 Suppl 14 2003 30 34 (Pubitemid 37445017)
7. M. Fava Pharmacological approaches to the treatment of residual symptoms J. Psychopharmacol. 20 2006 29 34 (Pubitemid 44605930)
8. S.E. Fehnel, C.M. Bann, S.L. Hogue, W.J. Kwong, and S.S. Mahajan The development and psychometric evaluation of the Motivation and Energy Inventory (MEI) Qual. Life Res. 13 2004 1321 1336 (Pubitemid 39149615)
9. P.P. Ferentinos, V.P. Kontaxakis, B.J. Havaki-Kontaxaki, K.G. Paplos, and C.R. Soldatos The measurement of fatigue in depression Psychopathology 40 2007 133 134 (Pubitemid 46220188)
10. P. Ferentinos, V. Kontaxakis, B. Havaki-Kontaxaki, D. Dikeos, and G. Papadimitriou The Fatigue Questionnaire: standardization in patients with major depression Psychiatry Res. 177 2010 114 119
11. J.D. Fisk, P.G. Ritvo, L. Ross, D.A. Haase, T.J. Marrie, and W.F. Schlech Measuring the functional impact of fatigue: initial validation of the fatigue impact scale Clin. Infect. Dis. 18 Suppl 1 1994 S79 S83 (Pubitemid 24023890)
12. Food and Drug Administration (FDA) Guidance for Industry-Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims 2009 FDA Silver Spring, MD
13. E. Guy ECDEU Assessment Manual for Psychopharmacology, Revised 1976 National Institute of Mental Health Rockville, MD
14. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
15. R.D. Hays, R.T. Anderson, and D.A. Revicki Assessing reliability and validity of measurement in clinical trials M.J. Staquet, R.D. Hays, P.M. Fayers, Quality of Life Assessment in Clinical Trials: Methods and Practice 1998 Oxford University Press New York 169 182
16. R. Jaeschke, J. Singer, and G.H. Guyatt Measurement of health status. Ascertaining the minimal clinically important difference Control. Clin. Trials 10 1989 407 415 (Pubitemid 20025670)
17. M.W. Johns A new method for measuring daytime sleepiness: the Epworth sleepiness scale Sleep 14 1991 540 545
18. L.L. Judd, H.S. Akiskal, J.D. Maser, P.J. Zeller, J. Endicott, W. Coryell, M.P. Paulus, J.L. Kunovac, A.C. Leon, T.I. Mueller, J.A. Rice, and M.B. Keller Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse J. Affect. Disord. 50 1998 97 108 (Pubitemid 28551779)
19. L.L. Judd, H.S. Akiskal, P.J. Zeller, M. Paulus, A.C. Leon, J.D. Maser, J. Endicott, W. Coryell, J.L. Kunovac, T.I. Mueller, J.P. Rice, and M.B. Keller Psychosocial disability during the long-term course of unipolar major depressive disorder Arch. Gen. Psychiatry 57 2000 375 380 (Pubitemid 30202328)
20. E.F. Juniper, G.H. Guyatt, A. Willan, and L.E. Griffith Determining a minimal important change in a disease-specific Quality of Life Questionnaire J. Clin. Epidemiol. 47 1994 81 87 (Pubitemid 24034293)
21. S.H. Kennedy Core symptoms of major depressive disorder: relevance to diagnosis and treatment Dialogues Clin. Neurosci. 10 2008 271 277
22. N. Kennedy, and E.S. Paykel Residual symptoms at remission from depression: impact on long-term outcome J. Affect. Disord. 80 2004 135 144 (Pubitemid 38597136)
23. K. Kroenke, and R.L. Spitzer The PHQ-9: a new depression diagnostic and severity measure Psychiatr. Ann. 32 2002 1 7
24. L.B. Krupp, N.G. LaRocca, J. Muir-Nash, and A.D. Steinberg The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus Arch. Neurol. 46 1989 1121 1123 (Pubitemid 19246303)
25. B.T. Kurian, T.L. Greer, and M.H. Trivedi Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms Expert. Rev. Neurother. 9 2009 975 984
26. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174 (Pubitemid 8054849)
27. N.K. Leidy, and M. Vernon Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment PharmacoEconomics 26 2008 363 370 (Pubitemid 351572050)
28. N.K. Leidy, D.A. Revicki, and B. Geneste Recommendations for evaluating the validity of quality of life claims for labeling and promotion Value Health 2 1999 113 127
29. S.M. Marcus, E.A. Young, K.B. Kerber, S. Kornstein, A.H. Farabaugh, J. Mitchell, S.R. Wisniewski, G.K. Balasubramani, M.H. Trivedi, and A.J. Rush Gender differences in depression: findings from the STAR*D study J. Affect. Disord. 87 2005 141 150 (Pubitemid 41039936)
30. S. Maurice-Tison, H. Verdoux, B. Gay, P. Perez, R. Salamon, and M.L. Bourgeois How to improve recognition and diagnosis of depressive syndromes using international diagnostic criteria Br. J. Gen. Pract. 48 1998 1245 1246 (Pubitemid 28221102)
31. T.R. Mendoza, X.S. Wang, C.S. Cleeland, M. Morrissey, B.A. Johnson, J.K. Wendt, and S.L. Huber The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory Cancer 85 1999 1186 1196 (Pubitemid 29115600)
32. M. Menza, H. Marin, and R.S. Opper Residual symptoms in depression: can treatment be symptom-specific? J. Clin. Psychiatry 64 2003 516 523 (Pubitemid 36618279)
33. H.J. Michielsen, J. De Vries, and G.L. Van Heck Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale J. Psychosom. Res. 54 2003 345 352 (Pubitemid 38365998)
34. J. Mintz, L.I. Mintz, M.J. Arruda, and S.S. Hwang Treatments of depression and the functional capacity to work Arch. Gen. Psychiatry 49 1992 761 768
35. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change Br. J. Psychiatry 134 1979 382 389 (Pubitemid 9136500)
36. A.A. Nierenberg, B.R. Keefe, V.C. Leslie, J.E. Alpert, J.A. Pava, J.J. Worthington III, J.F. Rosenbaum, and M. Fava Residual symptoms in depressed patients who respond acutely to fluoxetine J. Clin. Psychiatry 60 1999 221 225 (Pubitemid 29193918)
37. A.A. Nierenberg, M.M. Husain, M.H. Trivedi, M. Fava, D. Warden, S.R. Wisniewski, S. Miyahara, and A.J. Rush Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report Psychol. Med. 40 2010 41 50
38. J.C. Nunnally, and I.H. Bernstein Psychometric Theory 1994 McGraw-Hill New York
39. D.L. Nyenhuis, T. Luchetta, C. Yamamoto, A. Terrien, L. Bernardin, S.M. Rao, and D.C. Garron The development, standardization, and initial validation of the Chicago Multiscale Depression Inventory J. Pers. Assess. 70 1998 386 401 (Pubitemid 28347667)
40. J.S. Ogrodniczuk, W.E. Piper, and A.S. Joyce Residual symptoms in depressed patients who successfully respond to short-term psychotherapy J. Affect. Disord. 82 2004 469 473 (Pubitemid 39536181)
41. C.U. Pae, H.K. Lim, C. Han, A.A. Patkar, D.C. Steffens, P.S. Masand, and C. Lee Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion Expert. Rev. Neurother. 7 2007 1251 1263 (Pubitemid 350012717)
42. G.I. Papakostas, D.J. Nutt, L.A. Hallett, V.L. Tucker, A. Krishen, and M. Fava Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors Biol. Psychiatry 60 2006 1350 1355 (Pubitemid 44838537)
43. E.S. Paykel Remission and residual symptomatology in major depression Psychopathology 31 1998 5 14 (Pubitemid 28052440)
44. D.A. Revicki, D. Osoba, D. Fairclough, I. Barofsky, R. Berzon, N.K. Leidy, and M. Rothman Recommendations on health-related quality of life research to support labeling and promotional claims in the United States Qual. Life Res. 9 2000 887 900 (Pubitemid 32210183)
45. D. Revicki, R.D. Hays, D. Cella, and J. Sloan Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes J. Clin. Epidemiol. 61 2008 102 109
46. A.J. Rush, D.E. Giles, M.A. Schlesser, C.L. Fulton, J. Weissenburger, and C. Burns The Inventory for Depressive Symptomatology (IDS): preliminary findings Psychiatry Res. 18 1986 65 87 (Pubitemid 16085767)
47. A.J. Rush, C.M. Gullion, M.R. Basco, R.B. Jarrett, and M.H. Trivedi The Inventory of Depressive Symptomatology (IDS): psychometric properties Psychol. Med. 26 1996 477 486 (Pubitemid 26142491)
48. D.E. Stull, J. Krouse, E.O. Meltzer, L. Roberts, S. Kim, L. Frank, R. Naclerio, V. Lund, and A. Long Development and validation of the Congestion Quantifier seven-item test (CQ7): a screening tool for nasal congestion Value Health 10 2007 457 465 (Pubitemid 350013266)
49. R. Swindle, K. Kroenke, and L. Braun Energy and improved workplace productivity in depression Investing in Health: The Social and Economic Benefits of Health Care Innovation 2001 Elsevier Science Ltd. 323 341 (Pubitemid 33804918)
50. B. Tack A measure of fatigue in rheumatoid arthritis (abstract) Arthritis Care Res. 3 1990 S13
51. M.E. Thase, A.D. Simons, J. McGeary, J.F. Cahalane, C. Hughes, T. Harden, and E. Friedman Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment Am. J. Psychiatry 149 1992 1046 1052
52. A. Tylee, M. Gastpar, J.P. Lepine, and J. Mendlewicz DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee Int. Clin. Psychopharmacol. 14 1999 139 151 (Pubitemid 29348767)
53. J.E. Ware Jr., and C.D. Sherbourne The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med. Care 30 1992 473 483
54. C.-M. Yang, and C.-H. Wu The Situational Fatigue Scale: a different approach to measuring fatigue Qual. Life Res. 14 2005 1357 1362 (Pubitemid 40895757)